Self-Administered Medication Market Forecast, Trend Analysis & Competition Tracking – Global Market insights 2017 to 2026

  • Published : Nov-2017
  • Tables : 136
  • Figures : 84
  • Category : Healthcare
  • No. of Pages : 170
  • Report Code : FACT328MR
  • Format : ppt

Growing prevalence of chronic diseases has led to surge in the number of disabilities and cause of death. As prevalence of these diseases require frequent treatments, self-administered medication remains a cost-effective alternative. Increasing demand for self-treatment and healthcare management has led the self-administered medication market players to focus on developing medications and vaccinations that can be used for treatment at home.

self administered drugs market

According to Fact.MR, the global self-administered medication market is expected to represent a value of over US$ 100,000 Mn by the end of 2026.

Market Taxonomy

Region

Product Type

Route of Administration

Distribution Channel

North America

Insulin Pens

Oral

Hospital Pharmacies

Latin America

Opioid Pain Management

Subcutaneous

Retail Pharmacies

Europe

Prefilled Auto-injectors

Nasal

Online Pharmacies

Japan

Inhalers

Transdermal

 

APEJ

     

MEA

     

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

Chronic Diseases to Impact Self-Administered Medication Market Growth

Prevalence of chronic diseases such as arthritis, asthma, inflammation and gastrointestinal diseases will impact growth of the self-administered medication market. As treatment of these diseases include vaccinations regularly, frequent visits to the hospital can be an expensive option. Moreover, growing need for treatment in the emergency conditions such as asthma and bronchitis has led growth of self-administered medication market. Immediate treatment of chronic disorders is expected to rev up demand for nasal sprays, eye drops, ear drops and tablets that provide quick relief to the patients. Bound to such factors, the self-administered medication market will witness significant growth.

Collaborations to Underscore Growth Lucrative Opportunities

Recent trend witnessed show that the self-administered medication market players are increasingly collaborating with the delivery device companies in order to underscore lucrative opportunities. For instance, Takeda has recently collaborated with Portal Instruments in order to develop a needle-free drug delivery device for delivering biologic medicines. The Portal devices delivers biologic drugs through pressurized liquid instead of through the needles. As manufacturers are increasingly focusing on developing improved drug delivery devices, the self-administered medication market is expected to witness significant growth.

On the other hand, various factors are impacting growth of self-administered drugs negatively. Risks of making errors during the dosage administration practices is expected to impact the self-administered medication market adversely. Moreover, lack of awareness regarding various drug administration devices will further affect the global self-administered medication market growth negatively. In addition, improper designing or directions to use the drug delivery devices could pose significant challenges to self-administered medication market growth. Bound to these factors, the self-administered medication market will witness declined growth during the forecast period.

Inhalers to Represent a Leading Segment

Growing prevalence of asthma has led to an upsurge in demand for inhalers in the self-administered medication market. On the basis of product type, the inhalers will witness robust sales in self-administered medication market, accounting for a value of over US$ 20,000 Mn by 2026-end. On the other hand, the insulin product type segment is expected to register a robust CAGR through 2026.

Nasal route of administration will remain preferred in self-administered medication market, recording a value of over US$ 10,000 Mn by the end of 2017. In contrary to this, the transdermal route of administration segment is expected to register the highest CAGR through 2026.

By distribution channel, hospital pharmacies will spearhead the self-administered medication market, accounting for a value of over US$ 20,000 Mn by the end of 2026. However, the online pharmacies distribution channel segment is expected to register a healthy CAGR through 2026.

Competition Tracking                                                        

Leading players operating in the self-administered medication market include Abbott Laboratories, Purdue Pharma LP, Sanofi S.A., Pfizer, Inc., Mylan N.V., Novartis AG, Amgen Inc. and others.

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

Chapter 1 Global Outlook

Chapter 2 Global Self-Administered Drugs Market - Executive Summary

Chapter 3 Global Self-Administered Drugs Market Overview
3.1 Introduction
      3.1.1 Global Self-Administered Drugs Market Taxonomy
      3.1.2 Global Self-Administered Drugs Market Definition
3.2 Global Self-Administered Drugs Market Size (US$ Mn) and Forecast, 2012-2026
      3.2.1 Global Self-Administered Drugs Market Y-o-Y Growth
3.3 Global Self-Administered Drugs Market Dynamics
3.4 Supply Chain
3.5 Cost Structure
3.6 Pricing Analysis
3.7 PESTLE Analysis
3.8 Product Life Cycle Analysis
3.9 Epidemiology
3.10 Key Regulations
3.11 Patents
3.12 List of Distributors
3.13 Key Participants Market Presence (Intensity Map) By Region

Chapter 4 Global Self-Administered Drugs Market Analysis and Forecast 2012-2026
4.1 Global Self-Administered Drugs Market Size and Forecast By Product Type, 2012-2026
      4.1.1 Insulin Pens Market Size and Forecast, 2012-2026
              4.1.1.1 Revenue (US$ Mn) Comparison, By Region
              4.1.1.2 Market Share Comparison, By Region
              4.1.1.3 Y-o-Y growth Comparison, By Region
      4.1.2 Opioid Pain Management Market Size and Forecast, 2012-2026
              4.1.2.1 Revenue (US$ Mn) Comparison, By Region
              4.1.2.2 Market Share Comparison, By Region
              4.1.2.3 Y-o-Y growth Comparison, By Region
      4.1.3 Prefilled Auto-injectors Market Size and Forecast, 2012-2026
              4.1.3.1 Revenue (US$ Mn) Comparison, By Region
              4.1.3.2 Market Share Comparison, By Region
              4.1.3.3 Y-o-Y growth Comparison, By Region
      4.1.4 Inhalers Market Size and Forecast, 2012-2026
              4.1.4.1 Revenue (US$ Mn) Comparison, By Region
              4.1.4.2 Market Share Comparison, By Region
              4.1.4.3 Y-o-Y growth Comparison, By Region
4.2 Global Self-Administered Drugs Market Size and Forecast By Route of Administration, 2012-2026
      4.2.1 Oral Market Size and Forecast, 2012-2026
              4.2.1.1 Revenue (US$ Mn) Comparison, By Region
              4.2.1.2 Market Share Comparison, By Region
              4.2.1.3 Y-o-Y growth Comparison, By Region
      4.2.2 Subcutaneous Market Size and Forecast, 2012-2026
              4.2.2.1 Revenue (US$ Mn) Comparison, By Region
              4.2.2.2 Market Share Comparison, By Region
              4.2.2.3 Y-o-Y growth Comparison, By Region
      4.2.3 Nasal Market Size and Forecast, 2012-2026
              4.2.3.1 Revenue (US$ Mn) Comparison, By Region
              4.2.3.2 Market Share Comparison, By Region
              4.2.3.3 Y-o-Y growth Comparison, By Region
      4.2.4 Transdermal Market Size and Forecast, 2012-2026
              4.2.4.1 Revenue (US$ Mn) Comparison, By Region
              4.2.4.2 Market Share Comparison, By Region
              4.2.4.3 Y-o-Y growth Comparison, By Region
4.3 Global Self-Administered Drugs Market Size and Forecast By Distribution Channel, 2012-2026
      4.3.1 Hospital Pharmacies Market Size and Forecast, 2012-2026
              4.3.1.1 Revenue (US$ Mn) Comparison, By Region
              4.3.1.2 Market Share Comparison, By Region
              4.3.1.3 Y-o-Y growth Comparison, By Region
      4.3.2 Retail Pharmacies Market Size and Forecast, 2012-2026
              4.3.2.1 Revenue (US$ Mn) Comparison, By Region
              4.3.2.2 Market Share Comparison, By Region
              4.3.2.3 Y-o-Y growth Comparison, By Region
      4.3.3 Online Pharmacies Market Size and Forecast, 2012-2026
              4.3.3.1 Revenue (US$ Mn) Comparison, By Region
              4.3.3.2 Market Share Comparison, By Region
              4.3.3.3 Y-o-Y growth Comparison, By Region

Chapter 5 North America Self-Administered Drugs Market Size and Forecast, 2012-2026
5.1 North America Market Outlook
5.2 Revenue (US$ Mn) Comparison, By Country
5.3 Revenue (US$ Mn) Comparison, By Product Type
5.4 Revenue (US$ Mn) Comparison, By Route of Administration
5.5 Revenue (US$ Mn) Comparison, By Distribution Channel

Chapter 6 Latin America Self-Administered Drugs Market Size and Forecast, 2012-2026
6.1 Latin America Market Outlook
6.2 Revenue (US$ Mn) Comparison, By Country
6.3 Revenue (US$ Mn) Comparison, By Product Type
6.4 Revenue (US$ Mn) Comparison, By Route of Administration
6.5 Revenue (US$ Mn) Comparison, By Distribution Channel

Chapter 7 Europe Self-Administered Drugs Market Size and Forecast, 2012-2026
7.1 Europe Market Outlook
7.2 Revenue (US$ Mn) Comparison, By Country
7.3 Revenue (US$ Mn) Comparison, By Product Type
7.4 Revenue (US$ Mn) Comparison, By Route of Administration
7.5 Revenue (US$ Mn) Comparison, By Distribution Channel

Chapter 8 Japan Self-Administered Drugs Market Size and Forecast, 2012-2026
8.1 Japan Market Outlook
8.2 Revenue (US$ Mn) Comparison, By Country
8.3 Revenue (US$ Mn) Comparison, By Product Type
8.4 Revenue (US$ Mn) Comparison, By Route of Administration
8.5 Revenue (US$ Mn) Comparison, By Distribution Channel

Chapter 9 APEJ Self-Administered Drugs Market Size and Forecast, 2012-2026
9.1 APEJ Market Outlook
9.2 Revenue (US$ Mn) Comparison, By Country
9.3 Revenue (US$ Mn) Comparison, By Product Type
9.4 Revenue (US$ Mn) Comparison, By Route of Administration
9.5 Revenue (US$ Mn) Comparison, By Distribution Channel

Chapter 10 MEA Self-Administered Drugs Market Size and Forecast, 2012-2026
10.1 MEA Market Outlook
10.2 Revenue (US$ Mn) Comparison, By Country
10.3 Revenue (US$ Mn) Comparison, By Product Type
10.4 Revenue (US$ Mn) Comparison, By Route of Administration
10.5 Revenue (US$ Mn) Comparison, By Distribution Channel

Chapter 11 Global Self-Administered Drugs Market – Competitive Landscape and Company Profiles
11.1 Global Self-Administered Drugs Market – Company Share Analysis
11.2 Global Self-Administered Drugs Market – Competitive Landscape
11.3 Global Self-Administered Drugs Market – Company Profiles
      11.3.1 Abbott Laboratories
              11.3.1.1 Company Overview
              11.3.1.2 Product Overview
              11.3.1.3 Key Financials
              11.3.1.4 Key Developments
              11.3.1.5 SWOT Analysis
      11.3.2 Novartis AG
              11.3.2.1 Company Overview
              11.3.2.2 Product Overview
              11.3.2.3 Key Financials
              11.3.2.4 SWOT Analysis
      11.3.3 Mylan N.V.
              11.3.3.1 Company Overview
              11.3.3.2 Product Overview
              11.3.3.3 Key Financials
              11.3.3.4 Key Developments
              11.3.3.5 SWOT Analysis
      11.3.4 Becton, Dickinson and Company
              11.3.4.1 Company Overview
              11.3.4.2 Product Overview
              11.3.4.3 Key Financials
              11.3.4.4 SWOT Analysis
      11.3.5 Takeda Pharmaceutical Company Limited
              11.3.5.1 Company Overview
              11.3.5.2 Product Overview
              11.3.5.3 Key Financials
              11.3.5.4 Key Developments
              11.3.5.5 SWOT Analysis
      11.3.6 Amgen Inc.
              11.3.6.1 Company Overview
              11.3.6.2 Product Overview
              11.3.6.3 Key Financials
              11.3.6.4 SWOT Analysis
      11.3.7 Pfizer Inc.
              11.3.7.1 Company Overview
              11.3.7.2 Product Overview
              11.3.7.3 Key Financials
              11.3.7.4 Key Developments
              11.3.7.5 SWOT Analysis
      11.3.8 Sanofi
              11.3.8.1 Company Overview
              11.3.8.2 Product Overview
              11.3.8.3 Key Financials
              11.3.8.4 Key Developments
              11.3.8.5 SWOT Analysis
      11.3.9 Antares Pharma, Inc.
              11.3.9.1 Company Overview
              11.3.9.2 Product Overview
              11.3.9.3 Key Financials
              11.3.9.4 Key Developments
              11.3.9.5 SWOT Analysis
      11.3.10 Purdue Pharma L.P.
              11.3.10.1 Company Overview
              11.3.10.2 Product Overview
              11.3.10.3 Key Developments
              11.3.10.4 SWOT Analysis
11.4 Key Takeaways – Self-Administered Drugs Market

Chapter 12 Fact.MR Research Methodology

Chapter 13 Disclaimer

TABLE 1 Global Self-Administered Drugs Market Value (US$ Mn), 2012-2017
TABLE 2 Global Self-Administered Drugs Market Value (US$ Mn), 2018-2026
TABLE 3 Global Self-Administered Drugs Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4 Global Insulin Pens Segment Value (US$ Mn), By Region 2012-2017
TABLE 5 Global Insulin Pens Segment Value (US$ Mn), By Region 2018-2026
TABLE 6 Global Insulin Pens Segment Market Share, By Region 2012-2017
TABLE 7 Global Insulin Pens Segment Market Share, By Region 2018-2026
TABLE 8 Global Insulin Pens Segment Y-o-Y, By Region 2017-2026
TABLE 9 Global Opioid Pain Management Segment Value (US$ Mn), By Region 2012-2017
TABLE 10 Global Opioid Pain Management Segment Value (US$ Mn), By Region 2018-2026
TABLE 11 Global Opioid Pain Management Segment Market Share, By Region 2012-2017
TABLE 12 Global Opioid Pain Management Segment Market Share, By Region 2018-2026
TABLE 13 Global Opioid Pain Management Segment Y-o-Y, By Region 2017-2026
TABLE 14 Global Prefilled Auto-injectors Segment Value (US$ Mn), By Region 2012-2017
TABLE 15 Global Prefilled Auto-injectors Segment Value (US$ Mn), By Region 2018-2026
TABLE 16 Global Prefilled Auto-injectors Segment Market Share, By Region 2012-2017
TABLE 17 Global Prefilled Auto-injectors Segment Market Share, By Region 2018-2026
TABLE 18 Global Prefilled Auto-injectors Segment Y-o-Y, By Region 2017-2026
TABLE 19 Global Inhalers Segment Value (US$ Mn), By Region 2012-2017
TABLE 20 Global Inhalers Segment Value (US$ Mn), By Region 2018-2026
TABLE 21 Global Inhalers Segment Market Share, By Region 2012-2017
TABLE 22 Global Inhalers Segment Market Share, By Region 2018-2026
TABLE 23 Global Inhalers Segment Y-o-Y, By Region 2017-2026
TABLE 24 Global Oral Segment Value (US$ Mn), By Region 2012-2017
TABLE 25 Global Oral Segment Value (US$ Mn), By Region 2018-2026
TABLE 26 Global Oral Segment Market Share, By Region 2012-2017
TABLE 27 Global Oral Segment Market Share, By Region 2018-2026
TABLE 28 Global Oral Segment Y-o-Y, By Region 2017-2026
TABLE 29 Global Subcutaneous Segment Value (US$ Mn), By Region 2012-2017
TABLE 30 Global Subcutaneous Segment Value (US$ Mn), By Region 2018-2026
TABLE 31 Global Subcutaneous Segment Market Share, By Region 2012-2017
TABLE 32 Global Subcutaneous Segment Market Share, By Region 2018-2026
TABLE 33 Global Subcutaneous Segment Y-o-Y, By Region 2017-2026
TABLE 34 Global Nasal Segment Value (US$ Mn), By Region 2012-2017
TABLE 35 Global Nasal Segment Value (US$ Mn), By Region 2018-2026
TABLE 36 Global Nasal Segment Market Share, By Region 2012-2017
TABLE 37 Global Nasal Segment Market Share, By Region 2018-2026
TABLE 38 Global Nasal Segment Y-o-Y, By Region 2017-2026
TABLE 39 Global Transdermal Segment Value (US$ Mn), By Region 2012-2017
TABLE 40 Global Transdermal Segment Value (US$ Mn), By Region 2018-2026
TABLE 41 Global Transdermal Segment Market Share, By Region 2012-2017
TABLE 42 Global Transdermal Segment Market Share, By Region 2018-2026
TABLE 43 Global Transdermal Segment Y-o-Y, By Region 2017-2026
TABLE 44 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 45 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 46 Global Hospital Pharmacies Segment Market Share, By Region 2012-2017
TABLE 47 Global Hospital Pharmacies Segment Market Share, By Region 2018-2026
TABLE 48 Global Hospital Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 49 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 50 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 51 Global Retail Pharmacies Segment Market Share, By Region 2012-2017
TABLE 52 Global Retail Pharmacies Segment Market Share, By Region 2018-2026
TABLE 53 Global Retail Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 54 Global Online Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 55 Global Online Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 56 Global Online Pharmacies Segment Market Share, By Region 2012-2017
TABLE 57 Global Online Pharmacies Segment Market Share, By Region 2018-2026
TABLE 58 Global Online Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 59 North America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 60 North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 61 North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 62 North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 63 North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 64 North America Self-Administered Drugs Market Value (US$ Mn), By Country 2012-2017
TABLE 65 North America Self-Administered Drugs Market Value (US$ Mn), By Country 2018-2026
TABLE 66 North America Self-Administered Drugs Market Value (US$ Mn), By Product Type 2012-2017
TABLE 67 North America Self-Administered Drugs Market Value (US$ Mn), By Product Type 2018-2026
TABLE 68 North America Self-Administered Drugs Market Value (US$ Mn), By Route of Administration 2012-2017
TABLE 69 North America Self-Administered Drugs Market Value (US$ Mn), By Route of Administration 2018-2026
TABLE 70 North America Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 71 North America Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 72 Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 73 Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 74 Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 75 Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 76 Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 77 Latin America Self-Administered Drugs Market Value (US$ Mn), By Country 2012-2017
TABLE 78 Latin America Self-Administered Drugs Market Value (US$ Mn), By Country 2018-2026
TABLE 79 Latin America Self-Administered Drugs Market Value (US$ Mn), By Product Type 2012-2017
TABLE 80 Latin America Self-Administered Drugs Market Value (US$ Mn), By Product Type 2018-2026
TABLE 81 Latin America Self-Administered Drugs Market Value (US$ Mn), By Route of Administration 2012-2017
TABLE 82 Latin America Self-Administered Drugs Market Value (US$ Mn), By Route of Administration 2018-2026
TABLE 83 Latin America Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 84 Latin America Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 85 Europe Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 86 Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 87 Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 88 Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 89 Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 90 Europe Self-Administered Drugs Market Value (US$ Mn), By Country 2012-2017
TABLE 91 Europe Self-Administered Drugs Market Value (US$ Mn), By Country 2018-2026
TABLE 92 Europe Self-Administered Drugs Market Value (US$ Mn), By Product Type 2012-2017
TABLE 93 Europe Self-Administered Drugs Market Value (US$ Mn), By Product Type 2018-2026
TABLE 94 Europe Self-Administered Drugs Market Value (US$ Mn), By Route of Administration 2012-2017
TABLE 95 Europe Self-Administered Drugs Market Value (US$ Mn), By Route of Administration 2018-2026
TABLE 96 Europe Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 97 Europe Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 98 Japan Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 99 Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 100 Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 101 Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 102 Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 103 Japan Self-Administered Drugs Market Value (US$ Mn), By Country 2012-2017
TABLE 104 Japan Self-Administered Drugs Market Value (US$ Mn), By Country 2018-2026
TABLE 105 Japan Self-Administered Drugs Market Value (US$ Mn), By Product Type 2012-2017
TABLE 106 Japan Self-Administered Drugs Market Value (US$ Mn), By Product Type 2018-2026
TABLE 107 Japan Self-Administered Drugs Market Value (US$ Mn), By Route of Administration 2012-2017
TABLE 108 Japan Self-Administered Drugs Market Value (US$ Mn), By Route of Administration 2018-2026
TABLE 109 Japan Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 110 Japan Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 111 APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 112 APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 113 APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 114 APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 115 APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 116 APEJ Self-Administered Drugs Market Value (US$ Mn), By Country 2012-2017
TABLE 117 APEJ Self-Administered Drugs Market Value (US$ Mn), By Country 2018-2026
TABLE 118 APEJ Self-Administered Drugs Market Value (US$ Mn), By Product Type 2012-2017
TABLE 119 APEJ Self-Administered Drugs Market Value (US$ Mn), By Product Type 2018-2026
TABLE 120 APEJ Self-Administered Drugs Market Value (US$ Mn), By Route of Administration 2012-2017
TABLE 121 APEJ Self-Administered Drugs Market Value (US$ Mn), By Route of Administration 2018-2026
TABLE 122 APEJ Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 123 APEJ Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 124 MEA Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 125 MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 126 MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 127 MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 128 MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 129 MEA Self-Administered Drugs Market Value (US$ Mn), By Country 2012-2017
TABLE 130 MEA Self-Administered Drugs Market Value (US$ Mn), By Country 2018-2026
TABLE 131 MEA Self-Administered Drugs Market Value (US$ Mn), By Product Type 2012-2017
TABLE 132 MEA Self-Administered Drugs Market Value (US$ Mn), By Product Type 2018-2026
TABLE 133 MEA Self-Administered Drugs Market Value (US$ Mn), By Route of Administration 2012-2017
TABLE 134 MEA Self-Administered Drugs Market Value (US$ Mn), By Route of Administration 2018-2026
TABLE 135 MEA Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 136 MEA Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026

FIG. 1 Global Self-Administered Drugs Market Value (US$ Mn), 2012-2017
FIG. 2 Global Self-Administered Drugs Market Value (US$ Mn) Forecast, 2018-2026
FIG. 3 Global Self-Administered Drugs Market Value (US$ Mn) and Y-o-Y, 2017-2026
FIG. 4 Global Insulin Pens Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 5 Global Insulin Pens Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 6 Global Insulin Pens Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 7 Global Opioid Pain Management Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 8 Global Opioid Pain Management Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 9 Global Opioid Pain Management Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 10 Global Prefilled Auto-injectors Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 11 Global Prefilled Auto-injectors Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 12 Global Prefilled Auto-injectors Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 13 Global Inhalers Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 14 Global Inhalers Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 15 Global Inhalers Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 16 Global Oral Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 17 Global Oral Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 18 Global Oral Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 19 Global Subcutaneous Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 20 Global Subcutaneous Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 21 Global Subcutaneous Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 22 Global Nasal Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 23 Global Nasal Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 24 Global Nasal Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 25 Global Transdermal Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 26 Global Transdermal Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 27 Global Transdermal Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 28 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 29 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 30 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 31 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 32 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 33 Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 34 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 35 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 36 Global Online Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 37 North America Self-Administered Drugs Market Value (US$ Mn), By Country 2012-2017
FIG. 38 North America Self-Administered Drugs Market Value (US$ Mn), By Country 2018-2026
FIG. 39 North America Self-Administered Drugs Market Value (US$ Mn), By Product Type 2012-2017
FIG. 40 North America Self-Administered Drugs Market Value (US$ Mn), By Product Type 2018-2026
FIG. 41 North America Self-Administered Drugs Market Value (US$ Mn), By Route of Administration 2012-2017
FIG. 42 North America Self-Administered Drugs Market Value (US$ Mn), By Route of Administration 2018-2026
FIG. 43 North America Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 44 North America Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 45 Latin America Self-Administered Drugs Market Value (US$ Mn), By Country 2012-2017
FIG. 46 Latin America Self-Administered Drugs Market Value (US$ Mn), By Country 2018-2026
FIG. 47 Latin America Self-Administered Drugs Market Value (US$ Mn), By Product Type 2012-2017
FIG. 48 Latin America Self-Administered Drugs Market Value (US$ Mn), By Product Type 2018-2026
FIG. 49 Latin America Self-Administered Drugs Market Value (US$ Mn), By Route of Administration 2012-2017
FIG. 50 Latin America Self-Administered Drugs Market Value (US$ Mn), By Route of Administration 2018-2026
FIG. 51 Latin America Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 52 Latin America Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 53 Europe Self-Administered Drugs Market Value (US$ Mn), By Country 2012-2017
FIG. 54 Europe Self-Administered Drugs Market Value (US$ Mn), By Country 2018-2026
FIG. 55 Europe Self-Administered Drugs Market Value (US$ Mn), By Product Type 2012-2017
FIG. 56 Europe Self-Administered Drugs Market Value (US$ Mn), By Product Type 2018-2026
FIG. 57 Europe Self-Administered Drugs Market Value (US$ Mn), By Route of Administration 2012-2017
FIG. 58 Europe Self-Administered Drugs Market Value (US$ Mn), By Route of Administration 2018-2026
FIG. 59 Europe Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 60 Europe Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 61 Japan Self-Administered Drugs Market Value (US$ Mn), By Country 2012-2017
FIG. 62 Japan Self-Administered Drugs Market Value (US$ Mn), By Country 2018-2026
FIG. 63 Japan Self-Administered Drugs Market Value (US$ Mn), By Product Type 2012-2017
FIG. 64 Japan Self-Administered Drugs Market Value (US$ Mn), By Product Type 2018-2026
FIG. 65 Japan Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 66 Japan Self-Administered Drugs Market Value (US$ Mn), By Route of Administration 2018-2026
FIG. 67 Japan Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 68 Japan Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 69 APEJ Self-Administered Drugs Market Value (US$ Mn), By Country 2012-2017
FIG. 70 APEJ Self-Administered Drugs Market Value (US$ Mn), By Country 2018-2026
FIG. 71 APEJ Self-Administered Drugs Market Value (US$ Mn), By Product Type 2012-2017
FIG. 72 APEJ Self-Administered Drugs Market Value (US$ Mn), By Product Type 2018-2026
FIG. 73 APEJ Self-Administered Drugs Market Value (US$ Mn), By Route of Administration 2012-2017
FIG. 74 APEJ Self-Administered Drugs Market Value (US$ Mn), By Route of Administration 2018-2026
FIG. 75 APEJ Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 76 APEJ Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 77 MEA Self-Administered Drugs Market Value (US$ Mn), By Country 2012-2017
FIG. 78 MEA Self-Administered Drugs Market Value (US$ Mn), By Country 2018-2026
FIG. 79 MEA Self-Administered Drugs Market Value (US$ Mn), By Product Type 2012-2017
FIG. 80 MEA Self-Administered Drugs Market Value (US$ Mn), By Product Type 2018-2026
FIG. 81 MEA Self-Administered Drugs Market Value (US$ Mn), By Route of Administration 2012-2017
FIG. 82 MEA Self-Administered Drugs Market Value (US$ Mn), By Route of Administration 2018-2026
FIG. 83 MEA Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 84 MEA Self-Administered Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Benefits of Becoming a Fact.MR Client

  • Access to our global market coverage
  • Periodic updates on your sector
  • Exclusive discounts and offers
  • Greater flexibility for customization
  • Quick-research assistance for ad-hoc needs
  • Access to credible insights Fact.MR analyst interactions
  • Access to Fact.MR tools and research to fuel strategy development